Trials / Not Yet Recruiting
Not Yet RecruitingNCT06940700
Clinical Study on the Efficacy and Safety of SHR-4597 Inhalant in Adult Patients With Asthma
To Evaluate the Efficacy and Safety of SHR-4597 Inhalants in Adults With Asthma: a Multicenter, Randomized, Open-label, Positive-controlled Phase II Clinical Study
- Status
- Not Yet Recruiting
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- Sponsor
- Guangdong Hengrui Pharmaceutical Co., Ltd · Industry
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
To evaluate the efficacy and safety of SHR-4597 inhalants in adults with asthma: a multicenter, randomized, open-label, positive-controlled Phase II clinical study
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | SHR4597 | SHR4597 |
| DRUG | Budesonide inhalant | Budesonide inhalant |
Timeline
- Start date
- 2025-04-01
- Primary completion
- 2025-10-01
- Completion
- 2025-12-01
- First posted
- 2025-04-23
- Last updated
- 2025-04-23
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT06940700. Inclusion in this directory is not an endorsement.